✦ LIBER ✦

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial

✍ Scribed by Jocelyne Jacquemier; Jean-Marie Boher; Henri Roche; Benjamin Esterni; Daniel Serin; Pierre Kerbrat; Fabrice Andre; Pascal Finetti; Emmanuelle Charafe-Jauffret; Anne-Laure Martin; Mario Campone; Patrice Viens; Daniel Birnbaum; Frédérique Penault-Llorca; François Bertucci

Book ID: 118726820
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 339 KB
Volume: 13
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential Adjuvant Epirubicin-Based and

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

✍ Denlinger, C.S.; Goldstein, L.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The effect of body mass index on overall

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

✍ Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 307 KB

The effect of body mass index (BMI) on d

The effect of body mass index (BMI) on disease-free and overall survival in node-positive breast cancer treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

✍ E. De Azambuja; W. McCaskill-Stevens; E. Quinaux; M. Buyse; J. Crown; P. Francis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Prognostic and Predictive Value of Tumor

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

✍ Loi, S.; Sirtaine, N.; Piette, F.; Salgado, R.; Viale, G.; Van Eenoo, F.; Rouas, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 313 KB

Improved Disease-Free and Overall Surviv

Improved Disease-Free and Overall Survival with Dose-Dense Chemotherapy Compared with Conventional Chemotherapy in the Adjuvant Treatment of Node-Positive Breast Cancer: Results of a Randomized Study (CALGB 9741)

✍ Kavita Maung; Joyce A. O'Shaughnessy; George W. Sledge Jr. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Are patients in clinical trials represen

Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group

✍ Judith Fraser; Nicola Steele; Aysha Al Zaman; Alison Yule 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 146 KB